Search - tctmd.com

Displaying 21 - 40 of 134

Sort: Relevancy | Date

Presentation TCT 2017

Acute Kidney Injury As a PCI Quality Improvement Metric: Strengths and Weaknesses

Presenter: Somjot S. Brar, Roxana Mehran, Hitinder S. Gurm

November 01, 2017

Presentation TCT 2017

Acute Kidney Injury After TAVR: Frequency, Etiology, and Prevention

Presenter: Somjot S. Brar, Roxana Mehran, Ran Kornowski

November 01, 2017

Presentation TCT 2017

Acute Kidney Injury After PCI vs CABG: Which Is Preferred in the CKD Patient??

Presenter: Somjot S. Brar, Roxana Mehran, Anand Prasad

November 01, 2017

Presentation TCT 2017

Acute Kidney Injury in Cardiogenic Shock: Impact of Hemodynamic Support

Presenter: Somjot S. Brar, Roxana Mehran, Michael P. Flaherty

November 01, 2017

Presentation TCT 2017

Feasibility of PCI With No Contrast

Presenter: Patricia J. Best, Somjot S. Brar, Ziad A. Ali

November 01, 2017

Presentation TCT 2017

Strategies to Optimize Hydration for CIN Prevention

Presenter: Patricia J. Best, Somjot S. Brar

November 01, 2017

Presentation TCT 2017

Contrast Reduction Strategies in the Patient With CKD

Presenter: Patricia J. Best, Somjot S. Brar, Roxana Mehran

November 01, 2017

Presentation TCT 2017

CIN Risk Prediction and Contrast Volume: Data and Guidelines

Presenter: Patricia J. Best, Somjot S. Brar, Hitinder S. Gurm

November 01, 2017

Presentation TCT 2017

Contrast Induced Nephropathy: Why Does It Matter?

Presenter: Patricia J. Best, Somjot S. Brar, Carlo Briguori

November 01, 2017

News Conference News TCT 2017

Novel Percutaneous Suture-Based Solution for PFO Closure Shows Promise

Yael L. Maxwell

October 31, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day Two

Shelley Wood

October 31, 2017

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Todd Neale

October 30, 2017

Presentation TCT 2017

Effect of a New Enhanced Fluoroscopy Technology (Valve ASSIST2) on Contrast and Radiation Use in Patients Undergoing TAVR

Presenter: Nicolo Piazza, Josep Rodés-Cabau, Ali Shafiq

October 30, 2017

Presentation Stanford Coronary Physiology Conference 2017

Contrast FFR (cFFR): Pyramid of Diagnostic Accuracy

Presenter: Nils Johnson

October 28, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Daily News

NOAC Bleeding Risk Rises With Several Drug Combinations

Michael O'Riordan

October 06, 2017

News Daily News

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Michael O'Riordan

October 05, 2017

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

News Daily News

Stroke, Bleeding Risks High in A-fib Patients With Contraindications to Anticoagulation

Todd Neale

September 27, 2017

Advertisement

Acute Kidney Injury As a PCI Quality Improvement Metric: Strengths and Weaknesses

Acute Kidney Injury After TAVR: Frequency, Etiology, and Prevention

Acute Kidney Injury After PCI vs CABG: Which Is Preferred in the CKD Patient??

Acute Kidney Injury in Cardiogenic Shock: Impact of Hemodynamic Support

Feasibility of PCI With No Contrast

Strategies to Optimize Hydration for CIN Prevention

Contrast Reduction Strategies in the Patient With CKD

CIN Risk Prediction and Contrast Volume: Data and Guidelines

Contrast Induced Nephropathy: Why Does It Matter?

Novel Percutaneous Suture-Based Solution for PFO Closure Shows Promise

Live From Denver: TCT 2017, Day Two

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Effect of a New Enhanced Fluoroscopy Technology (Valve ASSIST2) on Contrast and Radiation Use in Patients Undergoing TAVR

Contrast FFR (cFFR): Pyramid of Diagnostic Accuracy

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

NOAC Bleeding Risk Rises With Several Drug Combinations

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Stroke, Bleeding Risks High in A-fib Patients With Contraindications to Anticoagulation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content